Zurcher Kantonalbank (Zurich Cantonalbank) Axogen, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$7.53 - $10.95 $94,930 - $138,046	12,607 New	12,607 $119,000
Q2 2022 Aug 09, 2022	SELL	$6.99 - $10.0 $14,839 - $21,230	-2,123 Closed	0 $0
Q2 2018 Aug 06, 2018	SELL	$36.15 - $52.5 $12,110 - $17,587	-335 Reduced 13.63%	2,123 $107,000
Q1 2018 May 03, 2018	BUY	$24.4 - $40.25 $23,692 - $39,082	971 Added 65.3%	2,458 $90,000
Q4 2017 Jan 31, 2018	BUY	$18.5 - $28.6 $27,509 - $42,528	1,487	1,487 $42,000

Others Institutions Holding AXGN

# of Institutions

162

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

First Light Asset Management, LLC Edina, MN

4.09M
Shares

$64 Million
5.0% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$50.8 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.01M
Shares

$47 Million
3.58% of portfolio
Morgan Stanley New York, NY

2.9M
Shares

$45.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$37.9 Million
0.0% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $661M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account